Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Jul 17, 2025

SELL
$9.27 - $11.41 $7,110 - $8,751
-767 Reduced 55.02%
627 $6,000
Q1 2025

Apr 21, 2025

BUY
$9.02 - $10.67 $6,936 - $8,205
769 Added 123.04%
1,394 $14,000
Q4 2024

Jan 30, 2025

BUY
$9.23 - $10.71 $1,873 - $2,174
203 Added 48.1%
625 $5,000
Q3 2024

Nov 07, 2024

BUY
$8.32 - $10.7 $1,339 - $1,722
161 Added 61.69%
422 $4,000
Q2 2024

Jul 24, 2024

SELL
$8.01 - $8.64 $248 - $267
-31 Reduced 10.62%
261 $2,000
Q4 2023

Jan 09, 2024

SELL
$7.78 - $8.62 $1,983 - $2,198
-255 Reduced 46.62%
292 $2,000
Q2 2023

Jul 12, 2023

BUY
$8.04 - $9.0 $1,519 - $1,701
189 Added 52.79%
547 $4,000
Q1 2023

Apr 20, 2023

SELL
$7.57 - $8.37 $15 - $16
-2 Reduced 0.56%
358 $2,000
Q4 2022

Jan 27, 2023

BUY
$5.96 - $8.06 $2,145 - $2,901
360 New
360 $0

Others Institutions Holding HLN

About Haleon plc


  • Ticker HLN
  • Exchange
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 4,617,290,240
  • Market Cap $44.3B
  • Description
  • Haleon plc engages in the research and development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides therapeutic oral health, pain relief, respiratory health, digestive health, and other products, as well as vitamins, mineral...
More about HLN
Track This Portfolio

Track Beacon Capital Management, LLC Portfolio

Follow Beacon Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Beacon Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Beacon Capital Management, LLC with notifications on news.